Financhill
Back

Atossa Therapeutics Stock Predictions

Atossa Therapeutics Stock Forecast

  • Is Atossa Therapeutics Stock Undervalued?
    The current Atossa Therapeutics [ATOS] share price is $1.46. The Score for ATOS is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
  • ATOS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Atossa Therapeutics Stock Go Up Next Year?

Data Unavailable

Atossa Therapeutics Stock Rating

Data Unavailable

Atossa Therapeutics Stock Price History

Is ATOS stock going to rise?

  • The current trend is moderately bearish and ATOS is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
atossatherapeutics.com

52-Week Data

52-Week High:
2.31
52-Week Low:
0.62

Prediction Charts

Market Cap:
183.61M
Price in USD:
1.46
Volume:
315.6K
Beta:
1.79

Technical Analysis

SMA50:
1.41
SMA100:
1.33
SMA200:
1.32
52-Wk Change:
121.21%

Stock Predictions

  • Is Atossa Therapeutics stock public?
    Yes, Atossa Therapeutics is a publicly traded company.
  • What is the Atossa Therapeutics stock quote today?
    The Atossa Therapeutics stock price is 1.46 USD today.
  • How to buy Atossa Therapeutics stock online?
    You can buy Atossa Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Oct-3 1.48 1.41 1.48 1.40
Oct-4 1.43 1.47 1.48 1.43
Oct-7 1.44 1.43 1.47 1.42
Oct-8 1.44 1.41 1.45 1.41
Oct-9 1.43 1.39 1.43 1.38
Oct-10 1.39 1.40 1.41 1.36
Oct-11 1.37 1.44 1.44 1.37
Oct-14 1.43 1.42 1.43 1.39
Oct-15 1.42 1.43 1.44 1.34
Oct-16 1.44 1.47 1.48 1.42
Oct-18 1.46 1.45 1.46 1.44
Oct-21 1.45 1.45 1.47 1.43
Oct-22 1.43 1.50 1.50 1.43
Oct-23 1.49 1.46 1.50 1.45

Atossa Therapeutics Earnings

Data Unavailable

Atossa Therapeutics Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.02 per share, and a decrease next year of $0.05 per share.

* Atossa Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.